MARKET

XXII

XXII

22ND CENTURY
AMEX

Real-time Quotes | Nasdaq Last Sale

0.6659
-0.0141
-2.07%
After Hours: 0.6750 +0.0091 +1.37% 17:55 04/03 EDT
OPEN
0.6760
PREV CLOSE
0.6800
HIGH
0.6900
LOW
0.6601
VOLUME
674.48K
TURNOVER
--
52 WEEK HIGH
2.460
52 WEEK LOW
0.6000
MARKET CAP
92.46M
P/E (TTM)
-3.1559
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average XXII stock price target is 11.50 with a high estimate of 11.50 and a low estimate of 11.50.

EPS

XXII News

More
  • Does The 22nd Century Group, Inc. (NYSEMKT:XXII) Share Price Fall With The Market?
  • Simply Wall St. · 03/23 14:08
  • 22nd Century Group, Inc. Files 2019 Annual Report
  • Business Wire · 03/12 11:50
  • 22ND Century Group Net Sales Revenue For Q4 Increased To $7.3M
  • Benzinga · 03/12 10:58
  • 22nd Century Announces Important New Achievements with KeyGene
  • GlobeNewswire · 03/11 21:15

Industry

Environmental Services & Equipment
-2.82%
Professional & Commercial Services
-1.87%

Hot Stocks

Symbol
Price
%Change

About XXII

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.
More

Webull offers kinds of 22nd Century Group Inc stock information, including AMEX:XXII real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XXII stock news, and many more online research tools to help you make informed decisions.